yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital. .
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful .
he let it ring and ring. "aren't you going to answer it?" his wife asked. "no, i know what's on the other line," olczyk said. .